Advances in Molecular Genetics and the Molecular Biology of DeafnessView this Special Issue
Research Article | Open Access
Makoto Hosoya, Masato Fujioka, Hideyuki Okano, Kaoru Ogawa, "Distinct Expression Pattern of a Deafness Gene, KIAA1199, in a Primate Cochlea", BioMed Research International, vol. 2016, Article ID 1781894, 8 pages, 2016. https://doi.org/10.1155/2016/1781894
Distinct Expression Pattern of a Deafness Gene, KIAA1199, in a Primate Cochlea
Deafness is one of the most common types of congenital impairments, and at least half of the cases are caused by hereditary mutations. Mutations of the gene KIAA1199 are associated with progressive hearing loss. Its expression is abundant in human cochlea, but interestingly the spatial expression patterns are different between mouse and rat cochleae; the pattern in humans has not been fully investigated. We performed immunohistochemical analysis of a nonhuman primate, common marmoset (Callithrix jacchus), cochlea with a KIAA1199-specific antibody. In the common marmoset cochlea, KIAA1199 protein expression was more widespread than in rodents, with all epithelial cells, including hair cells, expressing KIAA1199. Our results suggest that the primate pattern of KIAA1199 expression is wider in comparison with rodents and may play an essential role in the maintenance of cochlear epithelial cells.
Deafness is one of the most common types of congenital impairment, and at least half of all cases are caused by hereditary mutations. In some patients, hearing loss is progressive, with hearing loss developing gradually during childhood or youth after the acquisition of speech abilities. Mutation of the KIAA1199 gene is one cause of hereditary hearing loss .
KIAA genes were identified by sequence analysis of human large (>4 kb) cDNAs in the Kazusa cDNA sequencing project . KIAA1199 was found in a sequence of cDNA clones of unknown human genes from human adult and fetal brain cDNA libraries in 1999 . KIAA1199 was later identified by cDNA microarray analysis as a cochlea-specific gene that was abundantly expressed in the human cochlea , and the protein it encodes has been found to play a central role in hyaluronan binding and depolymerization . Recently, this gene became of interest in the cancer research field after clinical studies found it to have an involvement in cancer progression, metastasis, and poor prognosis of patients .
Signal cascade analyses revealed that KIAA1199 is a likely target gene of the Wnt/β-catenin signaling pathway , which is also known to be a key pathway in inner ear development  and regeneration . Mutations of KIAA1199 cause progressive hearing loss with a downsloping pattern, and usually the hearing impairment starts after acquisition of languages . In such postlingual hearing loss, in general, the auditory cortex has already developed and prevention of progressive hearing loss in the inner ear would be expected to be the most promising therapy for retaining long-term hearing ability; however, there is currently no such effective treatment for this condition. Thus, understanding the physiological functions of KIAA1199 and its pathophysiology when mutated is an important issue.
Transgenic or knockout animal models are powerful tools for clarifying disease mechanisms. In many genetic disorders, including hereditary hearing loss, their mechanisms have been unveiled by using animal models, especially transgenic or knockout mouse models . So far, no animal model harboring KIAA1199 mutations or its knockout has been reported. Expression analysis of KIAA1199 protein in the cochlea has been performed in mice and rats [1, 11], where different distribution patterns for each species were described, suggesting the possibility of an even greater difference in primates. We therefore examined expression of KIAA1199 protein by immunohistochemistry in cochlea from a nonhuman primate, the common marmoset (Callithrix jacchus).
2. Materials and Methods
2.1. Specimens of the Common Marmoset
Fixed and decapitated cadaverous heads of newborn common marmoset (postnatal day 2) and 3–6-year-old common marmosets were kindly provided by Junichi Hata, Reona Kobayashi, Takahiro Kondo, Kimika Yoshino-Saito, and Seiji Shiozawa. Fixed skin samples were also kindly provided. The animal experiments were approved by the Ethics Committee of Keio University (number 11006) and were in accordance with the guidelines of the National Institutes of Health and the Ministry of Education, Culture, Sports, Science, and Technology of Japan.
2.2. Tissue Preparation
Temporal bones from newborn and young adult marmosets were dissected, fixed, decalcified with Decalcifying Solution B (Wako, Saitama, Japan) for 3-4 weeks, and embedded in Tissue-Tek OCT compound (Sakura Finetek, Tokyo, Japan) for cryosections. The 7 μm sections were used for immunohistochemistry. Skin samples from young adult marmosets were dissected and fixed.
Temporal bones from 3-week-old mice (C57BL/6) and 3-month-old rats were dissected, fixed, decalcified with Decalcifying Solution B for 3–10 days, and embedded in Tissue-Tek OCT compound for cryosection. The 7 μm sections were used for immunohistochemistry. These animal experiments using mice were approved by the Ethics Committee of Keio University (number 08020) and were in accordance with the guidelines of the National Institutes of Health and the Ministry of Education, Culture, Sports, Science and Technology of Japan.
After a brief wash with phosphate-buffered saline (PBS) the sections were heated (80°C) in 10 mM citrate buffer (pH 6) for 1 h. After another brief wash, the sections were preblocked for 1 h at room temperature with 10% normal serum in PBS, incubated with primary antibodies at 4°C overnight, and then incubated with Alexa Fluor-conjugated secondary antibodies (Alexa488, Alexa555, and Alexa647) for 60 min at room temperature. The nuclei were counterstained with Hoechst 33342.
2.4. Whole-Mount Immunofluorescence
After 6 weeks of decalcifications of the cochlea of common marmoset, sensory epithelium containing organ of Corti was dissected. Sections were incubated with 10% normal serum in PBS for 1 h at room temperature and then with primary antibodies at 4°C overnight, followed by an incubation with Alexa Fluor-conjugated secondary antibodies (Alexa555 and Alexa647) and Phalloidin-conjugated Alexa488 (Thermo Fisher Scientific) for 60 min at room temperature. The nuclei were counterstained with Hoechst 33342.
The primary antibodies used in this study are as follows: anti-KIAA1199 (rabbit immunoglobulin G (IgG), Proteintech, Manchester, UK, 21129-1-AP, 1 : 50, rabbit IgG, Cosmo Bio, Tokyo, Japan, CNP-IP-208, 1 : 50), anti-SOX2 (goat IgG, Santa Cruz Biotechnology, Dallas, TX, US, sc17320, 1 : 100), anti-CTGF (goat IgG, Santa Cruz Biotechnology, sc14939, 1 : 100), anti-CALDESMON (Sigma-Aldrich, C0297, 1 : 100), anti-NKCC1 (goat IgG, Santa Cruz Biotechnology, sc21545, 1 : 300), anti-MYOSIN7a (mouse IgG, DSHB, Iowa City, IA, US, 138-1-s, 1 : 30), and anti-β-III TUBULIN (mouse IgG, Sigma-Aldrich, T8660, 1 : 250).
3. Results and Discussion
Recently we reported a brief document about the basic morphology and feasible methods for immunohistochemical analysis of the cochlea of the common marmoset (Callithrix jacchus) , which is a useful animal in modeling human disease by generating transgenic monkeys . The cochlea of marmosets has high similarity with that of humans in its basic morphology and protein distributions as defined by immunohistochemistry. Our previous results identified discrepancies in protein expression patterns in the cochlea between primates and rodents, indicating the necessity of studying primates, especially in regard to the deafness genes, where the typical human symptoms cannot be reproduced in mouse models; for example, see CX31  and CRYM .
In the common marmoset, KIAA1199 protein expression is observed in the lateral wall spiral ligament, hair cells, supporting cells, spiral limbus, and spiral ganglion neurons (Figure 1). No immunoreactivity was observed in Reissner’s membrane or beneath the basilar membrane.
In the spiral ligament, KIAA1199 expression was observed in type I, II, III, and V fibrocytes (Figure 2(a)). In the stria vascularis, KIAA1199 expression was observed in intermediate cells and basal cells, whereas no immunoreactivity was observed in NKCC1 positive marginal cells (Figure 2(b)). Notably, KIAA1199 immunoreactivity was relatively strong in the outer sulcus cell (Figure 2(c)).
In the organ of Corti, KIAA1199 expression was broadly observed in supporting cells between the inner and outer sulcus cells as well as the inner and outer hair cells (Figure 3). In the spiral ganglion neurons, KIAA1199 expression was observed in β-III tubulin positive neurons (Figure 4).
We also examined the expression of KIAA in the newborn of common marmoset. Immunoreactivities for KIAA1199 were observed in the lateral wall spiral ligament, hair cells, supporting cells, spiral limbus, and spiral ganglion neurons (Figure 5). The result indicates that this KIAA1199 expression pattern is maintained during their lifetime.
To validate the anti-KIAA1199 antibody (Proteintech) used in this study, we performed immunostaining in the skin of the common marmoset where both immunostaining and in situ hybridization were previously performed  (Figure 6(a)). Our results using the skin of common marmoset completely agreed with the previous reports of KIAA1199 expression in the skin of human. Next, we used another anti-KIAA1199 antibody (Cosmo Bio) to reconfirm our observations. The distribution patterns of the immunoreactivity for KIAA1199 using this other antibody was observed (Figure 6(b)). Furthermore, we stained the cochleae of mouse and rat with the antibodies used in this study (Figures 6(c) and 6(d)). In the mouse cochlea, immunoreactivities were detected in the lateral wall fibrocytes and the spiral limbus as previously reported . Of note, the presenting staining results in the rat cochlea with anti-KIAA1199 antibody completely matched those reported in a previous report .
The expression of KIAA1199 in the common marmoset was more widespread than that in the mouse or rat. Expression of KIAA1199 has been reported in the fibrocytes of the spiral ligament and the spiral limbus with a transient expression in Deiter’s cells at P0 in the mouse  (Table 1). In the rat, KIAA1199 expression was observed in supporting cells; however, its expression was not observed in hair cells and outer sulcus cells where obvious expression was detected in the common marmoset cochlea. In short, there is a large species difference in the pattern of KIAA1199 expression in the cochlea across mice, rats, and primates.
To understand the pathophysiology of a progressive hereditary hearing loss in patients, it is necessary to understand the roles of the deafness gene in the maintenance of hearing. Recently, in cancer research, a relationship between the Wnt/β-catenin signaling pathway and KIAA1199 was reported . KIAA1199 regulates the Wnt/β-catenin signaling pathway by interacting with ASCL2, LGR5, ITPR3, and Ca2+ signaling [6, 17, 18]. In the inner ear, Wnt/β-catenin signals are essential for the morphogenesis and regeneration of sensory and nonsensory epithelial cells [9, 19, 20]. The expression of KIAA1199 in the sensory epithelium in the marmoset, where Wnt activation is essential for its proliferation, may allow it to interact with the signal cascade and play an important role in cellular maintenance, as seen in cancer cells.
In a future study, functional analysis of KIAA1199 in the inner ear is necessary for understanding KIAA1199-related deafness. In such experiments, in general, generating transgenic or knockout mice is the first step. However, for KIAA1199, our observation showed large discrepancies of expression patterns in the cochlea between rodents and primates. Therefore, it is likely that a mouse model will fail to reproduce the hearing impairment observed in human patients. Thus, for an in vivo animal model, generating a transgenic primate model, such as a common marmoset, would be required.
KIAA1199 showed a primate-specific expression pattern in the cochlea. Future functional as well as mutation screening studies using primates will be crucial to understanding the mechanisms of KIAA1199-related hearing loss.
Hideyuki Okano is a founding scientist and a paid member in Scientific Advisory Board of SanBio Co., Ltd.
The authors thank Ayano Mitsui for their technical support and Junichi Hata, Reona Kobayashi, Takahiro Kondo, Kimika Yoshino-Saito, and Seiji Shiozawa for materials. Research was supported by JSPS Research Fellowships for Young Scientists (DC) to Makoto Hosoya, Research on Sensory and Communicative Disorders, MEXT, Grants-in-Aid for Scientific Research (C) and (B) (24592560, 15H04991), and Takeda Science Foundation to Masato Fujioka.
- S. Abe, S.-I. Usami, and Y. Nakamura, “Mutations in the gene encoding KIAA1199 protein, an inner-ear protein expressed in Deiters' cells and the fibrocytes, as the cause of nonsyndromic hearing loss,” Journal of Human Genetics, vol. 48, no. 11, pp. 564–570, 2003.
- M. Suyama, T. Nagase, and O. Ohara, “HUGE: a database for human large proteins identified by Kazusa cDNA sequencing project,” Nucleic Acids Research, vol. 27, no. 1, pp. 338–339, 1999.
- T. Nagase, K.-I. Ishikawa, R. Kikuno, M. Hirosawa, N. Nomura, and O. Ohara, “Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro,” DNA Research, vol. 6, no. 5, pp. 337–345, 1999.
- S. Abe, T. Katagiri, A. Saito-Hisaminato et al., “dentification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues,” The American Journal of Human Genetics, vol. 72, no. 1, pp. 73–82, 2003.
- H. Yoshida, A. Nagaoka, S. Nakamura, Y. Sugiyama, Y. Okada, and S. Inoue, “Murine homologue of the human KIAA1199 is implicated in hyaluronan binding and depolymerization,” FEBS Open Bio, vol. 3, pp. 352–356, 2013.
- Y. Zhang, S. Jia, and W. G. Jiang, “KIAA1199 and its biological role in human cancer and cancer cells (Review),” Oncology Reports, vol. 31, no. 4, pp. 1503–1508, 2014.
- J. Sabates-Bellver, L. G. Van der Flier, M. de Palo et al., “Transcriptome profile of human colorectal adenomas,” Molecular Cancer Research, vol. 5, no. 12, pp. 1263–1275, 2007.
- V. Munnamalai and D. M. Fekete, “Wnt signaling during cochlear development,” Seminars in Cell and Developmental Biology, vol. 24, no. 5, pp. 480–489, 2013.
- F. Shi, J. S. Kempfle, and A. S. B. Edge, “Wnt-responsive Lgr5-expressing stem cells are hair cell progenitors in the cochlea,” The Journal of Neuroscience, vol. 32, no. 28, pp. 9639–9684, 2012.
- L. M. Friedman, A. A. Dror, and K. B. Avraham, “Mouse models to study inner ear development and hereditary hearing loss,” The International Journal of Developmental Biology, vol. 51, pp. 609–631, 2007.
- S. Usami, Y. Takumi, N. Suzuki et al., “The localization of proteins encoded by CRYM, KIAA1199, UBA52, COL9A3, and COL9A1, genes highly expressed in the cochlea,” Neuroscience, vol. 154, no. 1, pp. 22–28, 2008.
- M. Hosoya, M. Fujioka, K. Ogawa, and H. Okano, “Distinct expression patterns of causative genes responsible for hereditary progressive hearing loss in non-human primate cochlea,” Scientific Reports, vol. 6, Article ID 22250, 2016.
- E. Sasaki, H. Suemizu, A. Shimada et al., “Generation of transgenic non-human primates with germline transmission,” Nature, vol. 459, pp. 523–527, 2009.
- A. Plum, E. Winterhager, J. Pesch et al., “Connexin31-deficiency in mice causes transient placental dysmorphogenesis but does not impair hearing and skin differentiation,” Developmental Biology, vol. 231, no. 2, pp. 334–347, 2001.
- S. Suzuki, N. Suzuki, J. Mori, A. Oshima, S. Usami, and K. Hashizume, “micro-Crystallin as an intracellular 3,5,3′-triiodothyronine holder in vivo,” Molecular Endocrinology, vol. 21, no. 4, pp. 885–894, 2007.
- H. Yoshida, A. Nagaoka, A. Kusaka-Kikushima et al., “KIAA1199, a deafness gene of unknown function, is a new hyaluronan binding protein involved in hyaluronan depolymerization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 14, pp. 5612–5617, 2013.
- K. Birkenkamp-Demtroder, A. Maghnouj, F. Mansilla et al., “Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells,” British Journal of Cancer, vol. 105, no. 4, pp. 552–561, 2011.
- A. Tiwari, M. Schneider, A. Fiorino et al., “Early insights into the function of KIAA1199, a markedly overexpressed protein in human colorectal tumors,” PLoS ONE, vol. 8, no. 7, article e69473, 2013.
- N. F. Bramhall, F. Shi, K. Arnold, K. Hochedlinger, and A. S. B. Edge, “Lgr5-positive supporting cells generate new hair cells in the postnatal cochlea,” Stem Cell Reports, vol. 2, no. 3, pp. 311–322, 2014.
- T. Wang, R. Chai, G. S. Kim et al., “Lgr5+ cells regenerate hair cells via proliferation and direct transdifferentiation in damaged neonatal mouse utricle,” Nature Communications, vol. 6, article 6613, 2015.
Copyright © 2016 Makoto Hosoya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.